From: Link between neurodegeneration and trabecular meshwork injury in glaucomatous patients
Age (y) | IOP (mm Hg) | Glaucoma Medications(n) | MD (dB) | |||||
---|---|---|---|---|---|---|---|---|
ρ | P | ρ | P | ρ | P | ρ | P | |
BDNF | 0.102 | 0.635 | −0.194 | 0.363 | 0.256 | 0.227 | 0.046 | 0.831 |
Cathepsin D | 0.418 | 0.042 | −0.146 | 0.496 | 0.115 | 0.594 | −0.668 | 0.000* |
sICAM-1 | 0.030 | 0.891 | −0.130 | 0.543 | −0.444 | 0.030 | −0.579 | 0.003* |
MPO | 0.023 | 0.916 | −0.036 | 0.868 | −0.192 | 0.369 | −0.340 | 0.104 |
sNCAM | −0.185 | 0.388 | −0.041 | 0.848 | −0.167 | 0.436 | −0.426 | 0.038 |
sVCAM-1 | 0.277 | 0.190 | 0.124 | 0.563 | −0.211 | 0.323 | −0.695 | 0.000* |
PAI-1 | −0.216 | 0.311 | −0.015 | 0.945 | −0.176 | 0.411 | −0.533 | 0.007* |